AstraZeneca's ANDA Litigation
Court Finds No General or Specific Personal Jurisdiction Exists
(1) Defendants have "repeatedly partnered" with New Jersey companies to develop pharmaceutical products, . . . ; (2) Defendants engaged a consultant from New Jersey; (3) Defendants have used a New Jersey Transfer Agent; (4) Defendants have sourced [*6] materials and equipment from New Jersey; (5) Defendants have paid "more taxes in New Jersey than the majority of, if not all, other states;" . . .; (6) Defendants have negotiated and entered confidentiality agreements with New Jersey entities; and (7) Defendants have "assert[ed] counterclaims in this Court," . . .
To view additional stories from Bloomberg Law® request a demo now